Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

THIOPENTAL vs THYMOCYTE IMMUNE GLOBULIN NOS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

THIOPENTAL vs THYMOCYTE IMMUNE GLOBULIN NOS: Safety Overview

Metric THIOPENTAL THYMOCYTE IMMUNE GLOBULIN NOS
Total FAERS Reports 1,048 5,559
Deaths Reported 211 1,474
Death Rate 20.1% 26.5%
Hospitalizations 428 2,161
Average Patient Age 31.5 yrs 35.4 yrs
% Female Patients 58.5% 49.3%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Marketing Status Discontinued N/A